Loss of promyelocytic leukemia protein in human gastric cancers

Cancer Letters

Volumn 247, Issue 1-2, 2007, Pages 103-109

  Lee, Hee Eun ^a   Jee, Chang Do ^a   Kim, Min A ^a   Lee, Hye Seung ^b   Lee, You Mie ^c   Lee, Byung Lan ^a   Kim, Woo Ho ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

Gastric cancers; Immunohistochemistry; PML protein; Proteasome inhibitor; Survival analysis; Tissue array analysis

Indexed keywords

PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEASOME; PROTEASOME INHIBITOR;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOMA; WESTERN BLOTTING;

CARCINOMA; CELL LINE, TUMOR; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 33845637936     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.03.034     Document Type: Article

References (27)

1. de The H., Chomienne C., Lanotte M., Degos L., and Dejean A. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347 (1990) 558-561
2. de The H., Lavau C., Marchio A., Chomienne C., Degos L., and Dejean A. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66 (1991) 675-684
3. Pandolfi P.P. Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia. Hum. Mol. Genet. 10 (2001) 769-775
4. Melnick A., and Licht J.D. Deconstructing a disease: RAR alpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93 (1999) 3167-3215
5. Weis K., Rambaud S., Lavau C., Jansen J., Carvalho T., Carmo-Fonseca M., et al. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76 (1994) 345-356
6. Dyck J.A., Maul G.G., Miller Jr. W.H., Chen J.D., Kakizuka A., and Evans R.M. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76 (1994) 333-343
7. Zhong S., Salomoni P., and Pandolfi P.P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2 (2000) E85-E90
8. Jensen K., Shiels C., and Freemont P.S. PML protein isoforms and the RBCC/TRIM motif. Oncogene 20 (2001) 7223-7233
9. Salomoni P., and Pandolfi P. The role of PML in tumor suppression. Cell 108 (2002) 165-170
10. Zhong S., Muller S., Ronchetti S., Freemont P., Dejean A., and Pandolfi P. Role of SUMO-1-modified PML in nuclear body formation. Blood 95 (2000) 2748-2752
11. Lallemand-Breitenbach V., Zhu J., Puvion F., Koken M., Honore N., Doubeikovsky A., et al. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193 (2001) 1361-1371
12. Zimber A., Nguyen Q.D., and Gespach C. Nuclear bodies and compartments: functional roles and cellular signalling in health and disease. Cell Signal. 16 (2004) 1085-1104
13. Wang Z.G., Ruggero D., Ronchetti S., Zhong S., Gaboli M., Rivi R., et al. PML is essential for multiple apoptotic pathways. Nat. Genet. 20 (1998) 266-272
14. Wang Z.G., Delva L., Gaboli M., Rivi R., Giorgio M., Cordon-Cardo C., et al. Role of PML in cell growth and the retinoic acid pathway. Science 279 (1998) 1547-1551
15. Rego E.M., Wang Z.G., Peruzzi D., He L.Z., Cordon-Cardo C., and Pandolfi P.P. Role of promyelocytic leukemia (PML) protein in tumor suppression. J. Exp. Med. 193 (2001) 521-529
16. Gambacorta M., Flenghi L., Fagioli M., Pileri S., Leoncini L., Bigerna B., et al. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am. J. Pathol. 149 (1996) 2023-2035
17. Koken M.H., Linares-Cruz G., Quignon F., Viron A., Chelbi-Alix M.K., Sobczak-Thepot J., et al. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10 (1995) 1315-1324
18. Zhang P., Chin W., Chow L.T., Chan A.S., Yim A.P., Leung S.F., et al. Lack of expression for the suppressor PML in human small cell lung carcinoma. Int. J. Cancer 85 (2000) 599-605
19. Gurrieri C., Capodieci P., Bernardi R., Scaglioni P.P., Nafa K., Rush L.J., et al. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J. Natl Cancer Inst. 96 (2004) 269-279
20. Chan J.Y., Chin W., Liew C.T., Chang K.S., and Johnson P.J. Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues. Eur. J. Cancer 34 (1998) 1015-1022
21. Cho Y., Lee I., Maul G., and Yn E. A novel nuclear substructure, ND10: distribution in normal and neoplastic human tissues. Int. J. Mol. Med. 1 (1998) 717-724
22. Kyrlagkitsis I., and Karamanolis D.G. Genes and gastric cancer. Hepatogastroenterology 51 (2004) 320-327
23. Lee H.S., Lee H.K., Kim H.S., Yang H.K., Kim Y.I., and Kim W.H. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators. Cancer 92 (2001) 1427-1434
24. Adams J. The proteasome: a suitable antineoplastic target. Nat. Rev. Cancer 4 (2004) 349-360
25. Maki C.G., Huibregtse J.M., and Howley P.M. In vivo ubiquitination and proteasome-mediated degradation of p53(1). Cancer Res. 56 (1996) 2649-2654
26. Pagano M., Tam S.W., Theodoras A.M., Beer-Romero P., Del Sal G., Chau V., et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269 (1995) 682-685
27. Goldberg A.L. Protein degradation and protection against misfolded or damaged proteins. Nature 426 (2003) 895-899